Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup

著录项

• 来源
  《Leukemia and lymphoma》 |2017年第10期|共4页
• 作者

  Ludwig Heinz; Dimopoulos Meletios A.; Moreau Philippe; Chng Wee-Joo; Goldschmidt Hartmut; Hajek Roman; Facon Thierry; Pour Ludek; Niesvizky Ruben; Oriol Albert; Rosinol Laura; Suvorov Aleksandr; Gaidano Gianluca; Pika Tomas; Weisel Katja; Goranova-Marinova Vesselina; Palumbo Antonio; Gillenwater Heidi H.; Mohamed Nehal; Aggarwal Sanjay; Feng Shibao; Joshua Douglas;

  展开▼
• 作者单位

  Wilhelminenspital Stadt Wien Wilhelminen Canc Res Inst Vienna Austria;

  Univ Athens Sch Med Athens Greece;

  Univ Nantes Nantes France;

  Natl Univ Singapore Canc Inst Singapore Singapore;

  Heidelberg Med Univ Heidelberg Germany;

  Univ Ostrava Univ Hosp Ostrava Ostrava Czech Republic;

  CHRU Lille Hop Claude Huriez Lille France;

  Univ Hosp Brno Brno Czech Republic;

  Weill Cornell Med Coll New York Presbyterian Hosp New York NY USA;

  Hosp Badalona Germans Trias &

  Pujol Inst Josep Carreras Inst Catala Oncol Barcelona Spain;

  Hosp Clin Barcelona Barcelona Spain;

  First Republican Clin Hosp Udmurtia Izhevsk Russia;

  Univ Piemonte Orientale Dept Translat Med Novara Italy;

  Univ Hosp Olomouc Olomouc Czech Republic;

  Univ Klinikum Tubingen Tubingen Germany;

  Univ Multiprofile Hosp Act Treatment Sv Georgi Plovdiv Bulgaria;

  Univ Turin Turin Italy;

  Onyx Pharmaceut Inc San Francisco CA USA;

  Onyx Pharmaceut Inc San Francisco CA USA;

  Onyx Pharmaceut Inc San Francisco CA USA;

  Royal Prince Alfred Hosp Camperdown NSW Australia;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词